Guanze Medical Information Industry (Holding) Co., Ltd. (Stock Code: 02427) and Funde (Hong Kong) Investment Holdings Co., Limited jointly announced a delay in the dispatch of their Composite Document related to a mandatory unconditional cash offer. The Composite Document, initially expected on or before 4 March 2026, has been deferred to a date on or before 10 April 2026.
The announcement states that additional time is required to prepare and finalize certain information, including the audited financial data for the year ended 31 December 2025. This information is targeted for publication by 31 March 2026. The executive arm of the relevant regulatory authority has indicated it is inclined to grant consent for the extended deadline.
Further updates will be released once the Composite Document and relevant acceptance forms are ready for dispatch or if the expected timeline changes.